Drug Manufacturing in a Time of Coronavirus
Summary: The COVID-19 pandemic has roiled R&D plans, created new priorities overnight and generally forced a major shift in many global manufacturing operations. This is an unprecedented time and we must work together to find innovative solutions at warp speed to beat COVID-19 and save lives.
In this webinar, John Carroll from Endpoints moderates a discussion between experts from Moderna, Sanofi Pasteur, Takeda and Catalent.